Solis, Dominador C.
HRN: 22-25-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
CEFTRIAXONE 1G (VIAL)
11/29/2022
12/05/2022
IV
1gram
Q12Hrs
CAP-MR; Covid-19 Pneumonia
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes